methotrexate has been researched along with Infections, Coronavirus in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 12 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aazami, H; Kamali, M; Khoshmirsafa, M; Mansouri, D; Mohsenzadegan, M; Pornour, M; Seif, F | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Durairaj, S; Khan, S | 1 |
| Nath, A; Safavi, F | 1 |
| Alvaro-Gracia, JM; Diaz-Torne, C; Gomez-Reino, J; Gonzalez-Gay, MA; Manero, J; Pego-Reigosa, JM; Rúa-Figueroa, Í; Sanchez-Piedra, C | 1 |
| Jindal, A; Noronha, M; Pai, K; Pai, S; Ramesh, S | 1 |
| Garg, PK; Kaul, P; Pasricha, R; Singh, MP | 1 |
| Lange, U; Müller-Ladner, U; Steinchen, N | 1 |
| Cruz, RA; Frohman, EM; Frohman, TC; Longmuir, R; Rowe, ES; Rowe, V; Steinman, L; Varkey, TC; Villemarette-Pittman, NR; Zamvil, SS | 1 |
| Mansouri, D; Pornour, M; Seif, F | 1 |
| Gasparyan, AY; Misra, DP; Zimba, O | 1 |
| Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V | 1 |
3 review(s) available for methotrexate and Infections, Coronavirus
| Article | Year |
|---|---|
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Janus Kinases; Methotrexate; Molecular Targeted Therapy; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Purines; Pyrazoles; Receptor, Angiotensin, Type 1; SARS-CoV-2; Signal Transduction; STAT Transcription Factors; Sulfonamides | 2020 |
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.
Topics: Betacoronavirus; Clinical Trial Protocols as Topic; Coronavirus Infections; COVID-19; Disease Management; Humans; Immunosuppressive Agents; Immunotherapy; Leucovorin; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
Topics: Antirheumatic Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hydroxychloroquine; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
9 other study(ies) available for methotrexate and Infections, Coronavirus
| Article | Year |
|---|---|
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Silencing of immune activation with methotrexate in patients with COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Immunosuppressive Agents; Inflammation; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Interleukin 1 Receptor Antagonist Protein; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Pandemics; Pneumonia, Viral; Rheumatic Diseases; Rituximab; SARS-CoV-2; Spain; Spondylarthropathies; Tumor Necrosis Factor Inhibitors | 2020 |
Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: An alternative in COVID-19.
Topics: Acrodermatitis; Administration, Topical; Adult; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2; Skin | 2020 |
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Methotrexate; Mouth Neoplasms; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
[Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy].
Topics: Antibodies, Viral; Arthritis, Rheumatoid; Betacoronavirus; Biological Therapy; Coronavirus Infections; COVID-19; Humans; Leflunomide; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Virus Activation | 2020 |
Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19.
Topics: Betacoronavirus; Biological Products; Coronavirus Infections; COVID-19; Humans; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Betacoronavirus; Biological Therapy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Drug Therapy, Combination; Humans; Lopinavir; Male; Methotrexate; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisolone; Ritonavir; SARS-CoV-2 | 2020 |